Zhirong Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhirong Sun has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Xue Shang
Departmentof Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, China
3 shared publications- Changhong Miao
Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China
2 shared publications Fan Yang
Departmentof Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, China
2 shared publicationsYi Liu
Departmentof Anesthesiology, Shanghai Cancer Center, Fudan University, Shanghai, China
2 shared publications- Bei-Bei Tao
Shanghai Key Laboratory of Bioactive Small Molecules, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University Shanghai Medical College, Shanghai, China
1 shared publication - Bo Xiong
Department of Anesthesiology, Shanghai Cancer Centre, Fudan University, Shanghai, 200032, China
1 shared publication
Latest Publications
- Open Access
- 12 January 2026
- Published by Springer Nature in Apoptosis
- Vol. 31 (1) , 42
Propofol attenuates angiogenesis by activating endoplasmic reticulum stress to suppress TFAP2C-driven VEGFA transcription
During anesthesia, significant hemodynamic changes often alter the vascular microenvironment and affecting endothelial cell behavior. Propofol, a commonly used intravenous anesthetic, has been widely studied for its role in tumor angiogenesis through tumor cell–derived VEGF–mediated endothelial interactions. However, its direct effects on endothelial cell–mediated angiogenesis in non-malignant diseases such as diabetic retinopathy, diabetic nephropathy, and coronary heart disease remain unclear. To address this gap, we examined the effects of propofol on VEGFA-mediated angiogenesis in vitro and in vivo. Mechanistically, propofol triggers endoplasmic reticulum stress by promoting phosphorylation of PERK and its downstream effector eIF2α, leading to suppressed translation of TFAP2C—a transcription factor critical for endothelial function. Further analysis revealed that TFAP2C directly binds to the VEGFA promoter to activate its transcription, thereby facilitating VEGFA/VEGFR2-dependent angiogenesis. Together, these findings not only broaden the understanding of propofol’s pharmacological profile, but also identify TFAP2C as a novel transcriptional regulator of VEGFA, offering new perspectives for therapeutic targeting of VEGFA-mediated angiogenesis. Graphical abstract Schematic representation of the mechanism of propofol inhibition of VEGFA/VEGFR2-associated angiogenesis via the PERK/eIF2α/TFAP2C axis.
- 12 January 2026
- Published by Springer Nature in Apoptosis
- Vol. 31 (1) , 42
Open AccessPropofol attenuates angiogenesis by activating endoplasmic reticulum stress to suppress TFAP2C-driven VEGFA transcription
During anesthesia, significant hemodynamic changes often alter the vascular microenvironment and affecting endothelial cell behavior. Propofol, a commonly used intravenous anesthetic, has been widely studied for its role in tumor angiogenesis through tumor cell–derived VEGF–mediated endothelial interactions. However, its direct effects on endothelial cell–mediated angiogenesis in non-malignant diseases such as diabetic retinopathy, diabetic nephropathy, and coronary heart disease remain unclear. To address this gap, we examined the effects of propofol on VEGFA-mediated angiogenesis in vitro and in vivo. Mechanistically, propofol triggers endoplasmic reticulum stress by promoting phosphorylation of PERK and its downstream effector eIF2α, leading to suppressed translation of TFAP2C—a transcription factor critical for endothelial function. Further analysis revealed that TFAP2C directly binds to the VEGFA promoter to activate its transcription, thereby facilitating VEGFA/VEGFR2-dependent angiogenesis. Together, these findings not only broaden the understanding of propofol’s pharmacological profile, but also identify TFAP2C as a novel transcriptional regulator of VEGFA, offering new perspectives for therapeutic targeting of VEGFA-mediated angiogenesis. Graphical abstract Schematic representation of the mechanism of propofol inhibition of VEGFA/VEGFR2-associated angiogenesis via the PERK/eIF2α/TFAP2C axis.
- Open Access
- 10 July 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-15
PLIN2 promotes colorectal cancer progression through CD36-mediated epithelial-mesenchymal transition
Colorectal cancer (CRC) is one of the most common malignant tumors with high incidence and mortality. The challenge remains to construct reliable prognostic prediction models and to further elucidate the key molecular mechanisms of tumor progression. To address this, we performed WGCNA based on 120 immune cell expression profiles from GEO sources to obtain a collection of monocytes/macrophages-related genes. The prognostic model was constructed by univariate survival analysis and LASSO regression analysis. Then, the prognostic model was validated by Multivariate Cox regression, Kaplan–Meier survival analysis and ROC analysis. In this prognostic model, we identified that PLIN2 has a potential value for CRC prognosis. PLIN2 expression in monocytes/macrophages was verified by scRNA-seq datasets and spatial transcriptome datasets, and PLIN2 was found to promote macrophage transformation to M2 subtype. Clinical specimens and tissue microarrays confirmed the differential expression and prognostic value of PLIN2 in CRC patients. Functional experiments demonstrated that PLIN2 gene overexpression promoted the proliferation, migration and invasion of CRC cells and significantly facilitated tumor growth in vivo. Mechanistically, we revealed that CD36 is a potential downstream target gene of PLIN2. The CD36 inhibitor Sulfo-N-succinimidyl Oleate significantly reversed PLIN2-induced proliferation, migration, invasion, and EMT activity of CRC cells in vitro and in vivo. Immunoprecipitation and immunofluorescence experiments confirmed that PLIN2 could interact with CD36. PLIN2 stabilized CD36 protein expression by inhibiting the proteasomal degradation pathway, thereby promoting CD36-mediated EMT activity. Overall, our study highlights that the PLIN2/CD36 axis regulates EMT activity and CRC progression, suggesting that interventions in this signaling pathway may offer a promising therapeutic approach to CRC progression.
- 10 July 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-15
Open AccessPLIN2 promotes colorectal cancer progression through CD36-mediated epithelial-mesenchymal transition
Colorectal cancer (CRC) is one of the most common malignant tumors with high incidence and mortality. The challenge remains to construct reliable prognostic prediction models and to further elucidate the key molecular mechanisms of tumor progression. To address this, we performed WGCNA based on 120 immune cell expression profiles from GEO sources to obtain a collection of monocytes/macrophages-related genes. The prognostic model was constructed by univariate survival analysis and LASSO regression analysis. Then, the prognostic model was validated by Multivariate Cox regression, Kaplan–Meier survival analysis and ROC analysis. In this prognostic model, we identified that PLIN2 has a potential value for CRC prognosis. PLIN2 expression in monocytes/macrophages was verified by scRNA-seq datasets and spatial transcriptome datasets, and PLIN2 was found to promote macrophage transformation to M2 subtype. Clinical specimens and tissue microarrays confirmed the differential expression and prognostic value of PLIN2 in CRC patients. Functional experiments demonstrated that PLIN2 gene overexpression promoted the proliferation, migration and invasion of CRC cells and significantly facilitated tumor growth in vivo. Mechanistically, we revealed that CD36 is a potential downstream target gene of PLIN2. The CD36 inhibitor Sulfo-N-succinimidyl Oleate significantly reversed PLIN2-induced proliferation, migration, invasion, and EMT activity of CRC cells in vitro and in vivo. Immunoprecipitation and immunofluorescence experiments confirmed that PLIN2 could interact with CD36. PLIN2 stabilized CD36 protein expression by inhibiting the proteasomal degradation pathway, thereby promoting CD36-mediated EMT activity. Overall, our study highlights that the PLIN2/CD36 axis regulates EMT activity and CRC progression, suggesting that interventions in this signaling pathway may offer a promising therapeutic approach to CRC progression.
- Open Access
- 30 April 2024
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (9) , e18336
Sirt7/HIC1 complex participates in hyperglycaemia‐mediated EndMT via modulation of SDC1 expression in diabetic kidney disease and metabolic memory
Diabetic kidney disease (DKD), a primary microvascular complication arising from diabetes, may result in end‐stage renal disease. Epigenetic regulation of endothelial mesenchymal transition (EndMT) has been recently reported to exert function in metabolic memory and DKD. Here, we investigated the mechanism which Sirt7 modulated EndMT in human glomerular endothelial cells (HGECs) in the occurrence of metabolic memory in DKD. Lower levels of SDC1 and Sirt7 were noted in the glomeruli of both DKD patients and diabetes‐induced renal injury rats, as well as in human glomerular endothelial cells (HGECs) with high blood sugar. Endothelial‐to‐mesenchymal transition (EndMT) was sustained despite the normalization of glycaemic control. We also found that Sirt7 overexpression associated with glucose normalization promoted the SDC1 expression and reversed EndMT in HGECs. Furthermore, the sh‐Sirt7‐mediated EndMT could be reversed by SDC1 overexpression. The ChIP assay revealed enrichment of Sirt7 and H3K18ac in the SDC1 promoter region. Furthermore, hypermethylated in cancer 1 (HIC1) was found to be associated with Sirt7. Overexpression of HIC1 with normoglycaemia reversed high glucose‐mediated EndMT in HGECs. The knockdown of HIC1‐mediated EndMT was reversed by SDC1 upregulation. In addition, the enrichment of HIC1 and Sirt7 was observed in the same promoter region of SDC1. The overexpressed Sirt7 reversed EndMT and improved renal function in insulin‐treated diabetic models. This study demonstrated that the hyperglycaemia‐mediated interaction between Sirt7 and HIC1 exerts a role in the metabolic memory in DKD by inactivating SDC1 transcription and mediating EndMT despite glucose normalization in HGECs.
- 30 April 2024
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (9) , e18336
Open AccessSirt7/HIC1 complex participates in hyperglycaemia‐mediated EndMT via modulation of SDC1 expression in diabetic kidney disease and metabolic memory
Diabetic kidney disease (DKD), a primary microvascular complication arising from diabetes, may result in end‐stage renal disease. Epigenetic regulation of endothelial mesenchymal transition (EndMT) has been recently reported to exert function in metabolic memory and DKD. Here, we investigated the mechanism which Sirt7 modulated EndMT in human glomerular endothelial cells (HGECs) in the occurrence of metabolic memory in DKD. Lower levels of SDC1 and Sirt7 were noted in the glomeruli of both DKD patients and diabetes‐induced renal injury rats, as well as in human glomerular endothelial cells (HGECs) with high blood sugar. Endothelial‐to‐mesenchymal transition (EndMT) was sustained despite the normalization of glycaemic control. We also found that Sirt7 overexpression associated with glucose normalization promoted the SDC1 expression and reversed EndMT in HGECs. Furthermore, the sh‐Sirt7‐mediated EndMT could be reversed by SDC1 overexpression. The ChIP assay revealed enrichment of Sirt7 and H3K18ac in the SDC1 promoter region. Furthermore, hypermethylated in cancer 1 (HIC1) was found to be associated with Sirt7. Overexpression of HIC1 with normoglycaemia reversed high glucose‐mediated EndMT in HGECs. The knockdown of HIC1‐mediated EndMT was reversed by SDC1 upregulation. In addition, the enrichment of HIC1 and Sirt7 was observed in the same promoter region of SDC1. The overexpressed Sirt7 reversed EndMT and improved renal function in insulin‐treated diabetic models. This study demonstrated that the hyperglycaemia‐mediated interaction between Sirt7 and HIC1 exerts a role in the metabolic memory in DKD by inactivating SDC1 transcription and mediating EndMT despite glucose normalization in HGECs.
- Open Access
- 28 April 2023
- Published by Springer Nature in Research Square
Hot spots and trends in inadvertent perioperative hypothermia: a bibliometric and visualized study
Purpose: Inadvertent perioperative hypothermia (IPH) is a common complication of anesthesia and surgical exposure. Although considerably increased attention has been paid to the role of IPH over the past decades, a systematical bibliometric analysis on this topic has not yet been performed. This study aimed to investigate current research hotspot and predict future trends in IPH research using bibliometric analysis. Methods: The relevant literatures published from 2000 to 2022 were identified and selected from the Science Citation Index Expanded of Web of Science Core Collection (WoSCC). The VOSviewer and CiteSpace software were used to perform collaboration network analysis, co-citation analysis, co-occurrence analysis, and citation burst detection. Results: 1685 publications (1450 articles and 235 reviews) from WoSCC were used for analysis and visualization. The United States has made the largest contribution in this field, with most publications (535, 31.8%), and closely collaborations with China and Canada. The most productive institution and scholar in this field were University of Sao Paulo (30, 1.8%) and Professor Braeuer (19, 1.13%), respectively. Anesthesia and Analgesia was the most productive journal. The top ten keywords based on the co-occurrence analysis are “hypothermia”, “cardiopulmonary bypass”, “body temperature, “anesthesia”, “surgery”, “cardiac surgery”, “damage control surgery”, “perioperative hypothermia”, “trauma”, “bleeding”. The emerging research hotspot might be “active warming “, “prewarming”, and “forced-air warming”. Conclusion: This study analyzed the IPH using bibliometric and visual analysis. These results provide an instructive perspective on the current research and future directions and give a potential foundation for further research and clinical applications.
- 28 April 2023
- Published by Springer Nature in Research Square
Open AccessHot spots and trends in inadvertent perioperative hypothermia: a bibliometric and visualized study
Purpose: Inadvertent perioperative hypothermia (IPH) is a common complication of anesthesia and surgical exposure. Although considerably increased attention has been paid to the role of IPH over the past decades, a systematical bibliometric analysis on this topic has not yet been performed. This study aimed to investigate current research hotspot and predict future trends in IPH research using bibliometric analysis. Methods: The relevant literatures published from 2000 to 2022 were identified and selected from the Science Citation Index Expanded of Web of Science Core Collection (WoSCC). The VOSviewer and CiteSpace software were used to perform collaboration network analysis, co-citation analysis, co-occurrence analysis, and citation burst detection. Results: 1685 publications (1450 articles and 235 reviews) from WoSCC were used for analysis and visualization. The United States has made the largest contribution in this field, with most publications (535, 31.8%), and closely collaborations with China and Canada. The most productive institution and scholar in this field were University of Sao Paulo (30, 1.8%) and Professor Braeuer (19, 1.13%), respectively. Anesthesia and Analgesia was the most productive journal. The top ten keywords based on the co-occurrence analysis are “hypothermia”, “cardiopulmonary bypass”, “body temperature, “anesthesia”, “surgery”, “cardiac surgery”, “damage control surgery”, “perioperative hypothermia”, “trauma”, “bleeding”. The emerging research hotspot might be “active warming “, “prewarming”, and “forced-air warming”. Conclusion: This study analyzed the IPH using bibliometric and visual analysis. These results provide an instructive perspective on the current research and future directions and give a potential foundation for further research and clinical applications.
- Open Access
- 28 December 2022
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 19 (1) , 1-5
Ginger supplement significantly reduced length of hospital stay in individuals with COVID-19
Background: Evidence from previous studies has suggested that ginger extract exhibits the potential as an alternative treatment for Coronavirus disease 2019 (COVID-19). Here, we want to investigate whether ginger supplement improves the clinical manifestation of hospitalized COVID-19 individuals.Methods: A total of 227 hospitalized individuals with COVID-19 were randomized to either the control (n = 132) or intervention group (n = 95). The intervention group took ginger supplement orally at the dosage of 1.5 g twice daily, until they were discharged from the hospital. Both groups received the same standard of general medical care during hospitalization, and the length of stay was recorded and compared between groups.Results: Among all participants, a significant reduction in hospitalization time (the difference between the treatment and control groups was 2.4 d, 95% CI 1.6–3.2) was detected in response to the ginger supplement. This effect was more pronounced in men, participants aged 60 years or older, and participants with pre-existing medical conditions, relative to their counterparts (P-interactions < 0.05 for all).Conclusion: Ginger supplement significantly shortened the length of stay of hospitalized individuals with COVID-19.Trial registration:The trial was registered on the Chinese Clinical Trial Registry (ChiCTR2200059824).
- 28 December 2022
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 19 (1) , 1-5
Open AccessGinger supplement significantly reduced length of hospital stay in individuals with COVID-19
Background: Evidence from previous studies has suggested that ginger extract exhibits the potential as an alternative treatment for Coronavirus disease 2019 (COVID-19). Here, we want to investigate whether ginger supplement improves the clinical manifestation of hospitalized COVID-19 individuals.Methods: A total of 227 hospitalized individuals with COVID-19 were randomized to either the control (n = 132) or intervention group (n = 95). The intervention group took ginger supplement orally at the dosage of 1.5 g twice daily, until they were discharged from the hospital. Both groups received the same standard of general medical care during hospitalization, and the length of stay was recorded and compared between groups.Results: Among all participants, a significant reduction in hospitalization time (the difference between the treatment and control groups was 2.4 d, 95% CI 1.6–3.2) was detected in response to the ginger supplement. This effect was more pronounced in men, participants aged 60 years or older, and participants with pre-existing medical conditions, relative to their counterparts (P-interactions < 0.05 for all).Conclusion: Ginger supplement significantly shortened the length of stay of hospitalized individuals with COVID-19.Trial registration:The trial was registered on the Chinese Clinical Trial Registry (ChiCTR2200059824).
- Open Access
- 30 March 2020
- Published by Springer Nature in Research Square
Feasibility of Intraoperative Neuromonitoring during Thyroid Surgery after Administration of Sugammadex for Reversal of Neuromuscular Blockade
The authors have requested that this preprint be removed from Research Square.
- 30 March 2020
- Published by Springer Nature in Research Square
Open AccessFeasibility of Intraoperative Neuromonitoring during Thyroid Surgery after Administration of Sugammadex for Reversal of Neuromuscular Blockade
The authors have requested that this preprint be removed from Research Square.
- 24 June 2019
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 40 (10) , 1303-1313
Propofol attenuates TNF-α-induced MMP-9 expression in human cerebral microvascular endothelial cells by inhibiting Ca2+/CAMK II/ERK/NF-κB signaling pathway
Metalloproteinase 9 (MMP-9) is able to degrade collagen IV, an important component of blood–brain barrier (BBB). Expression of MMPs, especially MMP-9, correlates with BBB disruption during central nervous system inflammation. Propofol has been reported to have anti-inflammation effects. In this study, we investigated the effects of propofol on TNF-α-induced MMP-9 expression in human cerebral microvascular endothelial cells (hCMEC/D3 cells) and explored the underlying mechanisms. The hCMEC/D3 cells were treated with propofol (25 μM), followed by TNF-α (25 ng/mL). We showed that TNF-α treatment markedly increased MMP-9 expression and decreased collagen IV expression in hCMEC/D3 cells, which was blocked by pretreatment with propofol. TNF-α-induced downregulation of collagen IV was also reversed by MMP-9 knockdown with siRNA. We revealed that TNF-α upregulated MMP-9 expression in hCMEC/D3 cells through activation of Ca2+/CAMK II/ERK/NF-κB signaling pathway; co-treatment with inhibitors of CaMK II (KN93), ERK (LY3214996), NF-κB (PDTC) or Ca2+chelator (BAPTA-AM) abrogated the effect of TNF-α on MMP-9 expression. We further established an in vitro BBB model by co-culturing of hCMEC/D3 cells and human astrocytes for 6 days and measuring trans-endothelial electrical resistance (TEER) to reflect the BBB permeability. TNF-α treatment markedly decreased TEER value, which was attenuated by pretreatment with propofol (25 μM) or MMP-9 knockdown with siRNA. In conclusion, propofol inhibits TNF-α-induced MMP-9 expression in hCMEC/D3 cells via repressing the Ca2+/CAMKII/ERK/NF-κB signaling pathway. TNF-α-impaired BBB integrity could be reversed by propofol, and propofol attenuates the inhibitory effect of TNF-α on collagen IV.
- 24 June 2019
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 40 (10) , 1303-1313
Propofol attenuates TNF-α-induced MMP-9 expression in human cerebral microvascular endothelial cells by inhibiting Ca2+/CAMK II/ERK/NF-κB signaling pathway
Metalloproteinase 9 (MMP-9) is able to degrade collagen IV, an important component of blood–brain barrier (BBB). Expression of MMPs, especially MMP-9, correlates with BBB disruption during central nervous system inflammation. Propofol has been reported to have anti-inflammation effects. In this study, we investigated the effects of propofol on TNF-α-induced MMP-9 expression in human cerebral microvascular endothelial cells (hCMEC/D3 cells) and explored the underlying mechanisms. The hCMEC/D3 cells were treated with propofol (25 μM), followed by TNF-α (25 ng/mL). We showed that TNF-α treatment markedly increased MMP-9 expression and decreased collagen IV expression in hCMEC/D3 cells, which was blocked by pretreatment with propofol. TNF-α-induced downregulation of collagen IV was also reversed by MMP-9 knockdown with siRNA. We revealed that TNF-α upregulated MMP-9 expression in hCMEC/D3 cells through activation of Ca2+/CAMK II/ERK/NF-κB signaling pathway; co-treatment with inhibitors of CaMK II (KN93), ERK (LY3214996), NF-κB (PDTC) or Ca2+chelator (BAPTA-AM) abrogated the effect of TNF-α on MMP-9 expression. We further established an in vitro BBB model by co-culturing of hCMEC/D3 cells and human astrocytes for 6 days and measuring trans-endothelial electrical resistance (TEER) to reflect the BBB permeability. TNF-α treatment markedly decreased TEER value, which was attenuated by pretreatment with propofol (25 μM) or MMP-9 knockdown with siRNA. In conclusion, propofol inhibits TNF-α-induced MMP-9 expression in hCMEC/D3 cells via repressing the Ca2+/CAMKII/ERK/NF-κB signaling pathway. TNF-α-impaired BBB integrity could be reversed by propofol, and propofol attenuates the inhibitory effect of TNF-α on collagen IV.